DIVISLAB vs RPGLIFE: Stock Comparison

Divis Laboratories Ltd vs RPG Life Sciences Limited

Live data: 22 July 2026, 3:02 PM IST • Source: NSE and company filings

Divis Laboratories Ltd is the larger company by market capitalisation. Divis Laboratories Ltd shows lower leverage, while RPG Life Sciences Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Divis Laboratories Ltd and RPG Life Sciences Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, DIVISLAB is more favourable on 4 of 13 scored metrics and RPGLIFE on 9These counts are context-free and are not an overall rating.

Key Differences

Market Cap
DIVISLAB is the larger company
₹1.96 L Cr vs ₹4,948 Cr
P/E Ratio
RPGLIFE has a lower P/E
43.37x vs 75.8x
P/B Ratio
RPGLIFE has a lower P/B
8.25x vs 11.61x
EPS
DIVISLAB has higher earnings per share
₹96.6 vs ₹69.65
Dividend Yield
RPGLIFE has a higher dividend yield
0.75% vs 0.41%
Revenue Growth (TTM YoY)
RPGLIFE has faster revenue growth
23.6% vs 9.5%
EPS Growth (TTM YoY)
DIVISLAB has faster EPS growth
13.6% vs -74.5%
Qtr Sales Growth
RPGLIFE has stronger quarterly sales growth
23.6% vs 9.52%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricDIVISLABRPGLIFE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricDIVISLABRPGLIFE
Live Price₹7,388₹3,001
Day Change0.79%0.1%
Volume3.26 L30,154
52-Week High₹7,438.5₹3,082
52-Week Low₹5,636.5₹1,733
Distance from 52W High-0.68%-2.63%

Valuation

MetricDIVISLABRPGLIFE
Market Cap₹1.96 L Cr₹4,948 Cr
P/E Ratio75.8x43.37x
P/B Ratio11.61x8.25x
EPS₹96.6₹69.65
Book Value₹631.37₹366.04
Dividend Yield0.41%0.75%

Growth

MetricDIVISLABRPGLIFE
Revenue Growth (TTM YoY)9.5%23.6%
EPS Growth (TTM YoY)13.6%-74.5%
Qtr Sales Growth9.52%23.6%
Qtr Profit Growth13.4%33.7%

Profitability & Leverage

MetricDIVISLABRPGLIFE
ROE16.5%19.3%
ROCE22%25.7%
Net Margin24.36%29.25%
Operating Margin32.6%20.9%
Debt to Equity0x0.03x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricDIVISLABRPGLIFE
Promoter Holding51.88%72.95%
FII Holding20.2% 0.09 pp0.87% 0.13 pp
DII Holding19.38% 0.16 pp7.45% 0.41 pp
Public Holding8.54% 0.06 pp18.73% 0.28 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Divis Laboratories Ltd and RPG Life Sciences Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.